Medical Communications

Showing 15 posts of 6411 posts found.

jakob-riis

Novo pledges single-digit cap on drug price hikes

December 7, 2016 Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk

Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …

Pfizer slapped with record £84.2 million fine for 2,600% price increase

December 7, 2016 Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine

Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …
jake_dupont

CMO of OncoMed Pharma resigns

December 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OncoMed Pharmaceuticals, a clinical-stage pharmaceutical company, announced that Jakob Dupont has resigned from his positions as the company’s senior vice …
sigurdur_olaffson_teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016 Manufacturing and Production, Medical Communications Teva, generics

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
jeffrey_eisenberg

Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xenetic

Xenetic Biosciences, a clinical-stage biopharmaceutical company, has announced the appointment of Jeffrey Eisenberg as chief operating officer. Mr. Eisenberg has …

Mission Therapeutics announces new non-executive chairman

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment

Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …
interactions-carousel

Scientists create ‘map of drugs’ to aid further development

December 5, 2016 Manufacturing and Production, Medical Communications

Researchers at The Institute of Cancer Research have used drugs licensed through the FDA to create a map of all …
veeva_commercial_summit

Veeva announces Veeva CRM Engage Meeting at European Commercial Summit

December 5, 2016 Medical Communications Big Data, CRM, veeva

Veeva, a cloud software company, concluded its annual European Commercial Summit last week, held this year in Madrid. The conference …

Pfizer teams up with IBM Watson Health in immuno-oncology

December 2, 2016 Medical Communications Pfizer, Watson, Watson Health, drug discovery, ibm

Pfizer and IBM Watson Health have announced a joint venture to accelerate research in immuno-oncology. Pfizer will use IBM’s Watson …
top_ten_1

Top Ten most popular articles on Pharmafile this week

December 2, 2016 Medical Communications November, news, pharmaceutical, top 10, top ten, top ten stories

This week has been an interesting one for pharmaceutical innovation. A number of stories and studies have arisen about trialling …

Looking back at the biggest deal of 2016: Bayer-Monsanto

December 2, 2016 Medical Communications Bayer, acquisition, big deal, monsanto, pharma deal 2016

The industry followed Bayer’s attempts to acquire US agricultural firm Monsanto with fevered anticipation; the takeover eventually closed in September …
shutterstock_274590824

J&J hit by $1bn hip implant lawsuit

December 2, 2016 Medical Communications J&J, JJ, lawsuit

Johnson & Johnson have been hit with yet another payout to patients who claim its products caused them harm. First, …
astrazeneca_building_white

AstraZeneca seals $1 billion deal with Bicycle Therapeutics

December 2, 2016 Medical Communications, Sales and Marketing AstraZeneca, Bicycle Therapeutics

Bicycle Therapeutics, Cambridge-based British biotech firm, has announced that it has signed a deal that could potentially be worth over …
The Gateway to Local Adoption Series

Latest content